J Mol Struct 5(1247):131327 Abdolmaleki S, Yarmohammadi N, Adibi H, Ghadermazi M, Ashengroph M, Rudbari HA, Bruno G (2019) Synthesis, X-ray studies, electrochemical properties, evaluation as in vitro cytotoxic and antibacterial agents of two antimony (III) complexes with dipicolinic acid
Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically starting at 2.5 mg for 4 weeks, then increasing by 2.5 mg every 4 weeks as tolerated to a maintenance dose of 5, 10, or 15 mg based on individual response
Considering the role of socioeconomic status in hospital outcomes measures
GLP-1 and Its Role in Diabetes Management GLP-1 is a hormone that enhances the secretion of insulin in response to elevated blood glucose levels